Antibodies

EVQLV and Libera Bio are collaborating to develop and deliver new antibodies for intracellular cancer targets

EVQLV Inc. and Libera Bio SL have signed a collaboration agreement to jointly address intracellular targets, some of the most elusive cancer targets that represent unmet medical needs. Antibodies can be designed to engage very specific targets along cancer pathways A lots of the best validated intracellular targets for cancer are considered “untreatable” because large …

EVQLV and Libera Bio are collaborating to develop and deliver new antibodies for intracellular cancer targets Read More »

Scientists have identified a new epitope at the furin cleavage site of the SARS-CoV-2 spike

Scientists have identified an immunogenic epitope at the furin cleavage site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that induces a robust antibody response in patients with coronavirus disease 2019 (COVID-19). In his study published in the journal eBiomedicine, researchers also identified a monoclonal antibody that binds to this epitope and protects mice from …

Scientists have identified a new epitope at the furin cleavage site of the SARS-CoV-2 spike Read More »